Skip to main content
Category

News Archive

ceres-nano-logo

Ceres Nanosciences reaches product development milestone for point-of-care Lyme disease test and closes on an additional $5.5M of Series A funding.

By News Archive

ceres-nano-logo

Ceres Nanosciences (Ceres) is announcing today that it has reached a key product development milestone for its Nanotrap® Lyme Antigen Test System. The Nanotrap® Lyme Antigen Test System will proceed into manufacturing and analytical performance testing this year and is on track for clinical study and FDA submission in 2019.

Read More
science-center-0618-logo.png

Rent hikes could force out UCity labs – Philadelphia Inquirer – Philly Edition, 2018-05-31

By News Archive

science-center-0618-logo.png

Philadelphia’s old brick residential neighborhoods aren’t the only part of the city that’s being gentrified.

The same thing is happening to University City’s rental lab space, where some rents are quadrupling. It’s a sign of success and the flood of investment boosting biotech firms. But it’s also a threat to startups that could force brainy startup leaders to flee to cheap space in the suburbs or go out of state, some university officials, start-up founders and young scientists say.

Read More
vlp-therapeutics-logo

VLP Therapeutics is Recognized by the Government of Japan (Cabinet Office) “Comprehensive Strategy on Science, Technology and Innovation for 2017” – VLP Therapeutics

By News Archive

vlp-therapeutics-logo

VLP Therapeutics is Recognized by the Government of Japan (Cabinet Office) “Comprehensive Strategy on Science, Technology and Innovation for 2017” VLP Therapeutics was recently recognized as one of eleven companies that exemplify Japan’s commitment to Innovation as outlined in the 2017 Comprehensive Strategy on Science, Technology and Innovation.

Read More
chappell perceptive logo

Perceptive Navigation Awarded $3 Million SBIR Grant to Commercialize the Vu-Path™ Ultrasound System

By News Archive

chappell perceptive logoPerceptive Navigation, LLC, a medical device company developing minimally-invasive, image-guidance solutions for the areas of cardiology, emergency medicine, and interventional radiology, announced today that it has been awarded a Phase IIB Small Business Innovation Research (SBIR) grant by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).  The award provides up to $3 million in funding to complete the product development and clinical work required to commercialize Perceptive’s first product, the Vu-PathTM Ultrasound System. This award comes as Perceptive completes work on a $1.4 million Phase II award from the NHLBI.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.